Leukemia therapeutics market to reach $27.41 billion by 2030 at 8.0% CAGR, driven by rising prevalence of leukemia.
Read More
Leukemia inhibitory factor (lif) market to reach $1.37 billion by 2030 at 8.2% CAGR, driven by increasing number of clinical trials and rising healthcare expenditure.
Read More
The global leukapheresis market to reach $104.27 billion by 2030 at 7.6% CAGR, driven by rise of autoimmune diseases.
Read More
Lentiviral vector market to reach $30.66 billion by 2030 at 12.8% CAGR, driven by increasing prevalence of chronic diseases.
Read More
Lennox gastaut syndrome market to reach $1.04 billion by 2030 at 6.9% CAGR, driven by increasing incidences of brain abnormalities.
Read More
Lenalidomide market to reach $17.83 billion by 2030 at 6.7% CAGR, driven by increase in prevalence of blood cancer cases.
Read More
Leiomyosarcoma drug market to reach $1.76 billion by 2030 at 8.3% CAGR, driven by growing investment in oncology research.
Read More
Lecithin supplements market to reach $3.22 billion by 2030 at 9.2% CAGR, driven by growing demand for dietary supplements.
Read More
The Laxatives market size is expected to reach $12.49 billion in 2030 at a CAGR of 8.2%, driven by rising gastric disorder prevalence.
Read More
Lateral Epicondylitis Treatment Market Insights Highlighting Opportunities Supporting Growth To 2030
The Lateral Epicondylitis Treatment market size is expected to reach $2.98 billion in 2030 at a CAGR of 4.9%, driven by growth in sports activities.
Read More